|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|
| Cash Flows from Operating Activities | |
| Net loss | |
| Adjustments to reconcile net loss to net cash used in operating activities | |
| Change in fair value of warrant liabilities | |
| Offering costs allocated to derivative warrant liabilities | |
| Interest earned on marketable securities in Trust Account | |
| Changes in operating assets and liabilities | |
| Prepaid expenses | |
| Other assets | |
| Accounts payable | |
| Franchise tax payable | |
| Accrued expenses | |
| Deferred legal fees | |
| Net cash used by operating activities | |
| Cash Flows from Investing Activities | |
| Cash deposited in Trust Account | |
| Net cash used in investing activities | |
| Cash Flows from Financing Activities | |
| Proceeds from issuance of Class A common stock and warrants | |
| Proceeds from note payable and advances from related party | |
| Repayment of note payable and advances from related party | |
| Payment of offering costs | |
| Net cash provided by financing activities | |
| Net increase in cash | |
| Cash—beginning of period | |
| Cash—end of period | |
| Supplemental disclosure of noncash investing and financing activities: | |
| Deferred legal fees related to Initial Public Offering | |
| Deferred underwriting compensation |
Loading...
